12670 studies found for:    Encephalopathy
Show Display Options
Rank Status Study
21 Terminated The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin
22 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
23 Completed Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
Conditions: Minimal Hepatic Encephalopathy;   Hepatic Encephalopathy
Intervention: Drug: Lactulose
24 Completed Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: Albumin
25 Suspended Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Dietary Supplement: Lactose-free milk;   Dietary Supplement: Whole milk
26 Not yet recruiting High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic Encephalopathy
Condition: Liver Cirrhosis
Interventions: Dietary Supplement: High protein diet;   Dietary Supplement: Normal protein
27 Completed Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: AST-120;   Drug: lactulose
28 Completed Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Condition: Hepatic Encephalopathy
Interventions: Drug: VSL#3;   Other: Placebo
29 Unknown  Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
Conditions: Hepatocerebral Encephalopathy;   Portal-Systemic Encephalopathy;   Encephalopathy, Hepatic;   Encephalopathy, Hepatocerebral
Interventions: Drug: Lactulose;   Drug: Placebo
30 Completed
Has Results
Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
Conditions: Hepatic Encephalopathy;   Cirrhosis;   Portosystemic Encephalopathy;   PSE
Interventions: Drug: Polyethylene glycol 3350-electrolyte solution (GoLYTELY®);   Drug: Lactulose
31 Completed Safety and Efficacy of Topiramate in Neonates With Hypoxic Ischemic Encephalopathy Treated With Hypothermia
Condition: Hypoxic Ischemic Encephalopathy
Intervention: Drug: Topiramate in newborns with hypoxic ischemic encephalopathy treated with therapeutic hypothermia
32 Unknown  RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin alone, Rifaximin combined with Lactulose
33 Recruiting Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
Condition: Encephalopathy, Hepatic
Interventions: Drug: Nitazoxanide;   Drug: Lactulose
34 Withdrawn Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Conditions: Hepatic Encephalopathy;   HE;   Cirrhosis;   Altered Mental Status;   AMS
Interventions: Drug: Lactulose;   Drug: Polyethylene Glycol 3350
35 Completed A Retrospective Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) (The RETRO Study)
Condition: Hepatic Encephalopathy
Intervention:
36 Active, not recruiting Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
Condition: Neonatal Hypoxic Ischemic Encephalopathy
Interventions: Biological: infusion of autologous cord blood;   Other: Neurodevelopmental outcomes
37 Not yet recruiting Correlation of Risk Factors and Severity of Hypoxic-ischaemic Encephalopathy
Condition: Hypoxic Ischaemic Encephalopathy
Intervention: Other: risk factors
38 Completed Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: L-Ornithine L-Aspartate
39 Completed AST-120 Used to Treat Mild Hepatic Encephalopathy
Condition: Mild Hepatic Encephalopathy
Intervention: Drug: AST-120
40 Recruiting Magnetic Resonance Biomarkers in Neonatal Encephalopathy
Condition: Neonatal Encephalopathy
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years